Search Results for: ALS

CIRM-funded stem cell-gene therapy shows promise in ALS safety trial

/ Esteban Cortez / 1 Comment

With funding support from the California Institute for Regenerative Medicine (CIRM), Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral … Continue reading CIRM-funded stem cell-gene therapy shows promise in ALS safety trial

How two women are fighting back against Lou Gehrig’s disease

/ Kevin McCormack / Leave a comment

THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Lou Gehrig’s disease, or ALS, is a nasty degenerative condition that destroys the brain cells controlling movement. People with ALS suffer a progressive loss of ability to walk, talk, eat and breathe. The average life expectancy for someone diagnosed with ALS is just two to five … Continue reading How two women are fighting back against Lou Gehrig’s disease

CIRM Board Approves New Clinical Trial for ALS

/ Yimy Villa / 8 Comments

This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $11.99 million to Cedars-Sinai to fund a clinical trial for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.  ALS is a neurodegenerative disease that results in the death of nerve cells in the brain and spinal cord, causing … Continue reading CIRM Board Approves New Clinical Trial for ALS

A step forward in finding a treatment for a deadly neurological disorder

/ Kevin McCormack / 2 Comments

THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a nasty disease that steadily attacks nerve cells in the brain and spinal cord. It’s pretty much always fatal within a few years. As if that wasn’t bad enough, ALS also can overlap with a … Continue reading A step forward in finding a treatment for a deadly neurological disorder

CIRM awards $1.5 million in lung health study for patients with Down Syndrome

/ California Institute for Regenerative Medicine (CIRM) / Leave a comment

The California Institute for Regenerative Medicine (CIRM) recently awarded $1.5 million to Denise Al Alam, PhD, of the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center to support research that aims to understand lung disease in individuals with Trisomy 21, also known as Down Syndrome. Although Trisomy 21 affects multiple organ systems, respiratory complications … Continue reading CIRM awards $1.5 million in lung health study for patients with Down Syndrome

CIRM awards $25 million for discovery and clinical research, infrastructure programs

/ California Institute for Regenerative Medicine (CIRM) / Leave a comment

The California Institute for Regenerative Medicine (CIRM) has recently approved awarding $25 million to fund multiple projects across discovery research, clinical research, and infrastructure programs. This funding will support 11 projects under CIRM’s Foundation Awards Program, which aims to drive rigorous studies addressing critical basic knowledge gaps in the biology of stem cells and regenerative … Continue reading CIRM awards $25 million for discovery and clinical research, infrastructure programs

Tratando malformaciones congénitas antes del nacimiento 

/ Esteban Cortez / Leave a comment

Michelle y Jeff se llenaron de felicidad cuando se enteraron de que iban a tener un bebé.   Luego, un examen de ultrasonido a las 20 semanas del embarazo reveló que el feto tenía espina bífida, una malformación congénita que ocurre cuando la columna vertebral y la médula espinal no se forman de manera adecuada. La … Continue reading Tratando malformaciones congénitas antes del nacimiento 

CIRM celebrates landmark 100+ clinical trial awards 

/ California Institute for Regenerative Medicine (CIRM) / Leave a comment

The California Institute for Regenerative Medicine (CIRM), California’s Stem Cell Agency and the world’s largest institution dedicated to regenerative medicine reached a milestone when it approved funding for its 100th clinical trial. At the February Independent Citizens’ Oversight Committee (ICOC) meeting, the board approved five new clinical trials for Parkinson’s disease, autoimmune conditions, cancers, and … Continue reading CIRM celebrates landmark 100+ clinical trial awards